Philip Morris International Advocates for a Pragmatic Approach to Health Innovation
Beyond technological advancements, the challenge now lies in transforming these progressions into tangible and accessible results on a large scale.
In an era where health innovation is often associated with technological progress, another question arises: that of its real impact. Speaking at GITEX Africa 2026, Taylan Süer, General Manager of the group, pleaded for a paradigm shift. "The challenge is not innovation itself, but its ability to produce concrete results," he affirmed. Behind this stance lies a shared observation that health systems innovate, but still struggle to translate these advancements into visible benefits for populations.
Due to inertia in behaviors, regulatory complexity, and fragmentation of devices, progress often remains limited in its deployment. This reality is particularly visible in the fight against smoking. Despite massive awareness campaigns, millions of adults continue to smoke, revealing a challenge that is more behavioral than informational.
In this context, Philip Morris International promotes an approach centered around three levers: prevention, support for smoking cessation, and development of reduced-risk alternatives. "Not all nicotine-based products have the same level of harm," Taylan Süer reminded, highlighting the potential of smoke-free products to reduce exposure to toxic substances.
When AI Helps Protect Consumers
With nearly a billion smokers worldwide, the question of large-scale impact becomes central. The company claims a progressive transformation of its model, marked by investments in smoke-free alternatives and a transition initiated among some adult consumers.
In this dynamic, artificial intelligence appears as a structuring lever. It enables the acceleration of research cycles, optimization of clinical trials, and improved exploitation of scientific data. "AI significantly reduces delays and improves the quality of decisions," the executive explained, highlighting its role in transforming health systems.
Beyond performance, its potential is particularly strategic in regions like Africa. By compensating for certain limitations related to infrastructure or resources, it opens the way to more agile models. "The continent has a unique opportunity to build 'digital-first' systems, without reproducing the heaviness observed elsewhere," he emphasized.
Reducing Risks
However, this technological acceleration poses an essential condition: trust. "If innovation moves faster than trust, it fails," Taylan Süer warned. To address this, several pillars are necessary: a solid scientific basis, adapted regulation, assumed transparency, and responsible use of artificial intelligence.
In a context where debates sometimes remain polarized, particularly around tobacco alternatives, the General Manager calls for overcoming oppositions. The challenge, according to him, lies in effectively reducing risks for adult smokers, which implies enhanced collaboration between regulators, health professionals, industry, and civil society.
In Tunisia, he notes an encouraging dynamic, driven by a growing openness to innovation and initiatives for cooperation between public and private actors. A fertile ground for experimenting with new models at the intersection of health, technology, and public policy.
Finally, there is the question of leadership. In complex environments, leadership no longer relies solely on vision, but on the ability to federate. Finding a balance between ambition and trust becomes crucial to inscribing these transformations in the long term.
